Mora, Andrea Clinical Associate Professor

academic article

• Panahi, L., Udeani, G., Horseman, M., Weston, J., Samuel, N., Joseph, M., Mora, A., & Bazan, D. (2021). Review of Medical Therapies for the Management of Pulmonary Embolism. 57(2), 110-110.
  
• Nowbakht, C., Edwards, A. R., Rodriguez-Buritica, D. F., Luce, A. M., Doshi, P. B., De Golovine, A., Bynon, J. S., & Nigo, M (2019). Two Cases of Fatal Hyperammonemia Syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients Outside Lung Transplant Recipients. Open Forum Infectious Diseases.  6(3), ofz033.
  
• Nigo, M., Luce, A. M., & Arias, C. A (2018). Long-term Use of Tedizolid as Suppressive Therapy for Recurrent Methicillin-Resistant Staphylococcus aureus Graft Infection. Clinical Infectious Diseases.  66(12), 1975-1976.
  
• Nesher, L., Hadi, C. M., Salazar, L., Wootton, S. H., Garey, K. W., Lasco, T., Luce, A. M., & Hasbun, R. (2016). Epidemiology of meningitis with a negative CSF Gram stain: under-utilization of available diagnostic tests. 189-197.
  
• Phe, K., Shields, R. K., Tverdek, F. P., Aitken, S. L., Guervil, D. J., Lam, W., ... Tam, V. H. (2016). Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study. Journal of Antimicrobial Chemotherapy.  3585-3587.
  
• Pham, V. P., Luce, A. M., Ruppelt, S. C., Wei, W., Aitken, S. L., Musick, W. L., Roux, R. K., & Garey, K. W. (2015). Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole. Antimicrobial Agents and Chemotherapy.  6113-6116.
  
• Winans, S. A., Luce, A. M., & Hasbun, R (2013). Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone. Infection: journal of infectious disease.  41(4), 769-774.
  
• Mora, A. L., Salazar, M., Pablo-Caeiro, J., Frost, C. P., Yadav, Y., DuPont, H. L., & Garey, K. W (2012). Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection. American Journal of the Medical Sciences.  343(4), 277-280.